The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Blood Platelet-Rich Plasma market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Blood Platelet-Rich Plasma
Platelet-rich plasma has got many applications in the healthcare industry, especially in areas such as orthopedic surgeries, treatment of sports injuries and treatment of neurological diseases, amongst others. In platelet-rich plasma therapy, a platelet-rich gel is used in which the concentration of platelets is much higher, more than four to eight times higher than the concentration of normal blood platelets.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=170
Market Snapshot
According to Fact.MR, the platelet-rich plasma market is slated to touch an impressive valuation of around US$ 1.5 Bn surpassing a CAGR of 12% during the assessment period.
The market remains influenced by its integral use in the healthcare industry, especially in orthopedic surgeries and cosmetic surgeries. Injuries like the rotator cuff, tendon injuries, tennis elbow, and hamstring among others are healed quickly and effectively with the help of platelet-rich plasma therapy.
The report offers actionable and valuable market insights of Blood Platelet-Rich Plasma. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Blood Platelet-Rich Plasma Market across various industries and regions.
This newly published and insightful report sheds light on Market Insights of Blood Platelet-Rich Plasma, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Blood Platelet-Rich Plasma Market. The scope of Fact.MR’s report is to analyze the global platelet-rich plasma market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis.
Platelet-rich plasma therapy providers, research institutes, and key players in the global platelet-rich plasma market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to platelet-rich plasma therapy.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=170
Key Segments Covered
-
Product Type
- Platelet-Rich Plasma Instruments
- Pure Platelet-Rich Plasma Kits
- Leucocyte-Rich Platelet-Rich Plasma Kits
- Platelet-Rich Fibrin Kits
- Pure Platelet-Rich Fibrin Kits
-
Application
- Platelet-Rich Plasma for Orthopedic Surgery
- Platelet-Rich Plasma for Cosmetic Surgery
- Platelet-Rich Plasma for General Surgery
- Platelet-Rich Plasma for Neurosurgery
- Platelet-Rich Plasma for Other Surgeries
Competitive Landscape
The market is moderately competitive and is divided into companies that are expected to remain active in the expansion of the global platelet-rich plasma market through 2031.
Players focus on adopting various strategies to expand product offerings and strengthen geographic presence. With the advancement in technology, new players are expected to enter the market.
- In February 2021, Atlas Health Medical Group announced PRP availability (Platelet Rich Plasma) Microneedling Facelifts to patients. In addition to this, in February 2020, EmCyte completed the acquisition of Cellmedix Holdings LLC, including all the assets of the U.S.-based company such as the proprietary product system, namely Centrepid Platelet Concentrator.
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/170
Key Takeaways from the Market Study
- Pure platelet-rich plasma kits demand surpassed 50% as of 2020, expected to sustain through 2031
- By application, demand likely to remain strong across orthopedic surgeries, exhibiting a robust 10% CAGR
- Hospitals to dominate the end-user segment through 2031, registering 10% CAGR
- Cosmetic surgery to turn into a lucrative segment, attributed to rising haircare industry
- U.S to generate high demand, expanding at around 9% CAGR across the forecast period
- The UK to remain the dominating country in Europe, likely to expand at around 8% CAGR
- India likely to exhibit substantial opportunity, approximating a CAGR of 8% through 2031
“Continued onslaught of COVID-19 is anticipated to keep demand for platelet-rich plasma therapy elevated, as healthcare providers strive to discover possible breakthroughs in its applications to eradicate the novel coronavirus,” says the Fact.MR analyst.
For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com